Frederik Verelst - Ctr Hlth Econ Res & Modelling Infect Dis, Univ Antwerp

基本信息

Career Trajectory

Bio

Frederik Verelst currently works at the Centre for Health Economics Research and Modeling of Infectious Diseases, University of Antwerp. Frederik does research in Health Economics, Health Policy, Epidemiology and Infectious Diseases. Their most recent publication is 'Lessons from a decade of individual-based models for infectious disease transmission: A systematic review (2006-2015)'.

Research Interests

Papers共 30 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA

Hiral Anil Shah, Ginita Jutlla,Oscar Herrera-Restrepo,Jonathan Graham, Mei Grace, Shah Alam Khan, Elise Kuylen, Shahina Begum,Frederik Verelst,Zeki Kocaata

PharmacoEconomicsno. 6 (2025): 651-664

Cited0Views0WOSBibtex

Older Adults' and Physicians' Preferences for Respiratory Syncytial Virus Vaccination in Germany and Italy: A Discrete Choice Experiment

Alen Marijam, Pavo Marijic, Anna Puggina, Olivier Cailloux,Frederik Verelst, Marta Vicentini,Elisa Turriani, Foteini Gkalapi, Indra Jaidhauser, Christina Rieger,Paolo Bonanni,Chiara de Waure,Gernot Rohde, Tommi Tervonen

Vaccine (2025): 127390-127390

Cited0Views0WOSBibtex

Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention among Older Adults in the United States

Daniel Molnar,Elizabeth M. La,Frederik Verelst,Sara Poston,Jonathan Graham,Laure-Anne Van Bellinghen,Desmond Curran

Infectious Diseases and Therapypp.1-18, (2024)

Cited5Views0WOSBibtex

Cost-effectiveness of the Adjuvanted RSVPreF3 Vaccine among Adults Aged ≥60 Years in the United States

Elizabeth M. La,Jonathan Graham,David Singer,Daniel Molnar,Sara Poston,Desmond Curran, Jessica Pickett,Frederik Verelst

HUMAN VACCINES & IMMUNOTHERAPEUTICSno. 1 (2024)

Cited0Views0WOSBibtex

The Potential Public Health Impact of the Respiratory Syncytial Virus Prefusion F Protein Vaccine in People Aged ≥60 Years in Japan: Results of a Markov Model Analysis

Daisuke Kurai,Akiko Mizukami, Victor Preckler,Frederik Verelst,Daniel Molnar,Taizo Matsuki,Yufan Ho,Ataru Igarashi

EXPERT REVIEW OF VACCINESno. 1 (2024): 303-311

Cited2Views0WOSBibtex

Cost-effectiveness Analysis of Respiratory Syncytial Virus Vaccination with the Adjuvanted Prefusion F Protein Vaccine (rsvpref3 OA) for Adults ≥60 Years Old in Japan

Akiko Mizukami, Victor Preckler,Frederik Verelst,Taizo Matsuki,Yufan Ho,Daisuke Kurai,Daniel Molnar

EXPERT REVIEW OF VACCINESno. 1 (2024): 986-996

Cited0Views0WOSBibtex

EE331 Leveraging Time-Use Data to Estimate Market and Non-Market Productivity Losses Due to Respiratory Syncytial Virus (RSV) Disease among Adults Aged ≥60 Years in the United States (US)

F. Verelst,Em La,J. Graham, D. Molnar

Value in Health（2023）

Cited0Views0Bibtex

EPH45 Assessing the Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine among Older Adults in the United States (US)

D. Molnar,E. M. La,F. Verelst,D. Curran,S. Poston,L. A. Van Bellinghen,J. Graham

Value in Healthno. 6 (2023): S172-S172

Cited0Views0Bibtex

The Influence of Risk Perceptions on Close Contact Frequency During the SARS-CoV-2 Pandemic

James Wambua,Lisa Hermans,Pietro Coletti,Frederik Verelst,Lander Willem,Christopher I. Jarvis,Amy Gimma,Kerry L. M. Wong,Adrien Lajot,Stefaan Demarest,W. John Edmunds,Christel Faes,Philippe Beutels,Niel Hens

Scientific Reports（2022）

Cited20Views0WOSNATUREBibtex

Different Forms of Superspreading Lead to Different Outcomes: Heterogeneity in Infectiousness and Contact Behavior Relevant for the Case of SARS-CoV-2

Elise J. Kuylen,Andrea Torneri,Lander Willem,Pieter J. K. Libin,Steven Abrams,Pietro Coletti,Nicolas Franco,Frederik Verelst,Philippe Beutels,Jori Liesenborgs,Niel Hens

PLoS Computational Biology（2022）

Cited5Views0WOSEIBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn